In nodal B-cell lymphoma, an anti-CD20 bispecific antibody combined with either anti-CD39 or anti-CD73 antibodies exhibits a synergistic effect, leading to increased cytokine secretion, T-cell proliferation, and tumor cell cytotoxicity [324]. This evidence concerns the gene ENTPD1 and B-cell non-Hodgkin lymphoma.